Zorbtive [somatropin (rDNA origin) for injection]





The Zorbtive Resource Center offers easy-to-read information specifically for people with Short Bowel Syndrome who are considering Zorbtive treatment to potentially reduce their need for I.V. parenteral nutrition (PN). "Understanding Zorbtive Treatment," our patient handbook, can be read online or printed. The handbook has a Frequently Asked Questions flyer tucked inside. There is also the Zorbtive Patient Information Leaflet and the Zorbtive Full Prescribing Information, to tell you about treatment, potential benefits of treatment, and possible side effects.				The Zorbtive Resource Center also has clinical information for health professionals who treat SBS, available by filling out a brief Clinical Information Request Form. A Treatment Guideline for Zorbtive is part of our clinical library, as well as A Clinical Review for Zorbtive, summarizing a selection of key studies. There is also a journal article reprint from the Annals of Surgery, containing Zorbtive pivotal trial data. A Statement of Medical Necessity is available to be downloaded or printed.

Zorbtive® [somatropin (rDNA origin) for injection] is indicated for the treatment of Short Bowel Syndrome (SBS) in patients receiving specialized nutritional support. Optimal management of SBS may include dietary adjustments, enteral feedings, parenteral nutrition, and fluid and micronutrient supplements, as needed. Some common side effects of Zorbtive treatment include muscle and joint pain, and fluid retention (swelling). Zorbtive may also cause serious side effects such as inflammation of the pancreas (pancreatitis), diabetes or other blood sugar problems, pain, numbness or tingling in the wrist and hand, or increased blood pressure in the brain. Make sure and talk with your doctor about these side effects. Do not take Zorbtive if you have any of the following serious medical conditions: open-heart surgery; stomach-area (abdominal) surgery; an accident; breathing problems (respiratory failure); cancer; or, allergy to Zorbtive or other growth hormone medications. This information is not intended to replace discussions with your healthcare professional. For additional information about Zorbtive, please read the Zorbtive Patient Information Leaflet and Zorbtive Full Prescribing Information and talk to your doctor. You can also call SeroCare^SM toll free at 800-714-2437. Zorbtive is available by prescription only. This Web site was developed by EMD Serono, Inc. (emdserono.com), makers of Zorbtive, to educate SBS patients and interested healthcare professionals about this treatment for Short Bowel Syndrome. Zorbtive is exclusively marketed by Emmaus Medical, Inc. (emmausmedical.com), Tel: 1-877-420-6493. This site contains medical information that is intended for residents of the United States only and is not meant to substitute for the advice provided by a medical professional. Always consult a doctor if you have health concerns. Use and access of this site is subject to the terms and conditions as set out in our Legal Statement and Privacy Policy. © 2007 EMD Serono, Inc. All rights reserved.